Risk factors associated with the occurrence of clinical deterioration after cessation of beclomethasone in asthmatic children and adolescents

M. T. M. Fonseca, P. A. M. Camargos, L. M. B. Lasmar (Belo Horizonte, Brazil)

Source: Annual Congress 2004 - Epidemiology of childhood asthma
Session: Epidemiology of childhood asthma
Session type: Thematic Poster Session
Number: 2422
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. T. M. Fonseca, P. A. M. Camargos, L. M. B. Lasmar (Belo Horizonte, Brazil). Risk factors associated with the occurrence of clinical deterioration after cessation of beclomethasone in asthmatic children and adolescents. Eur Respir J 2004; 24: Suppl. 48, 2422

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors for asthma exacerbation in children and adolescents
Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations
Year: 2018

Factors associated with medication adherence in school-aged children with asthma
Source: ERJ Open Res 2016
Year: 2016



“Factors associated with medication adherence in school-aged children with asthma.”
Source: ERJ Open Res 2016: 00087-2015-ERR
Year: 2016



Long-term ICS in preschool children at high risk for asthma
Source: ISSN=ISSN 1810-6838, ISBN=, page=72
Year: 2006

Risk factors for current asthma symptoms in young adolescents
Source: Annual Congress 2010 - Paediatric epidemiology: asthma and associated factors
Year: 2010


Risk factors for severe asthma among adults with asthma
Source: Virtual Congress 2020 – Diagnosis and management of asthma
Year: 2020




Risk factors for severe bronchial asthma in young adults with childhood-onset asthma
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007


Factors predicting the development of asthma in wheezing children
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017

Factors influencing adherence to beclomethasone in children with persistent asthma in a low-income country: a randomized concurrent cohort study
Source: Eur Respir J 2005; 26: Suppl. 49, 450s
Year: 2005

Efficacy of tezepelumab in adolescents with severe, uncontrolled asthma
Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science
Year: 2021



Risk factors for severe asthma attacks in Romanian children
Source: Eur Respir J 2006; 28: Suppl. 50, 253s
Year: 2006

Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017

Incidence of asthma and wheeze among teenagers is associated with environmental risk factors
Source: Annual Congress 2012 - Epidemiology of asthma
Year: 2012


Risk factors associated with repeated hospitalization for asthma attacks in children
Source: Eur Respir J 2004; 24: Suppl. 48, 389s
Year: 2004

Factors with impact on postponing asthma diagnosis in children
Source: Annual Congress 2009 - Clinical advances in childhood asthma
Year: 2009


Effect of maintenance oral corticosteroids on risk factors for frequent exacerbations in a severe adult asthma population
Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes
Year: 2020




Risk factors associated with poor asthma control and quality of life in severe Spanish asthmatics
Source: Annual Congress 2011 - Asthma: improving diagnosis and management for reaching better control
Year: 2011


Risk factors associated with hospitalized asthma patients
Source: Eur Respir J 2001; 18: Suppl. 33, 51s
Year: 2001

Early life risk factors for asthma outcomes in a cohort of young adults
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016